ORAL SOLUTION COMPRISING ATOMOXETINE HYDROCHLORIDE

Oral aqueous solutions comprising atomoxetine hydrochloride as active ingredient and a liquid carrier comprising xylitol, maltitol and a sweetener which is selected from the group consisting of sucralose, saccharin, sodium or calcium saccharin, stevioside and rebaudioside. The pH of the solution is...

Full description

Saved in:
Bibliographic Details
Main Authors ARGYRO STAPPA, ILIAS KOTSIANIS, ANGELOS KARATZAS, KONSTANTINOS APOSTOLOU
Format Patent
LanguageEnglish
Portuguese
Published 18.01.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Oral aqueous solutions comprising atomoxetine hydrochloride as active ingredient and a liquid carrier comprising xylitol, maltitol and a sweetener which is selected from the group consisting of sucralose, saccharin, sodium or calcium saccharin, stevioside and rebaudioside. The pH of the solution is adjusted to the range of 3.5 to 4.5. The solutions of the present invention are palatable even in the absence of further polyhydric or sugar alcohols, in addition to xylitol and maltitol.
Bibliography:Application Number: PT20140726544T